EMJ Podcast: Insights For Healthcare Professionals

Our latest podcast features Robert Dellavalle, Professor of Dermatology, Colorado School of Medicine, Professor of Public Health at the Colorado School of Public Health, and physician at the University of Colorado Hospital, all based in Aurora, Colorado, USA. Dellavalle and our host, Jonathan Sackier, discuss all things dermatology, from different skin conditions to community outreach programmes and the rise of telemedicine.

This EMJ Podcast, hosted by Gemma Boak, research scientist and health advocate, explores how psychology can be used to optimise the management of treatment for women with psoriasis. Boak is joined by Rob Horne, Professor of Behavioural Medicine and Director of the Centre for Behavioural Medicine, University College London (UCL) School of Pharmacy, UK, who shares expertise from his research, focusing on the role of psychological and behavioural factors in explaining variations in treatment responses.

Delving into some of the challenges that physicians face in the clinic, this podcast addresses women with psoriasis who hold strong doubts about their need for treatment, challenges around discussing family planning with patients, and pruritis as a life-quality limiting factor. The podcast ends by questioning listeners: what can dermatologists do to optimise the management of women with psoriasis?

This educational podcast has been funded by UCB, in which the position and discussions might not necessarily represent the position of UCB.

This week, Jonathan is joined by Fred T. Lee Jr., Professor of Radiology, Biomedical Engineering, and Urology at the University of Wisconsin–Madison, USA. The pair discuss Lee’s career path into the field of radiology, while detailing aspects of his father, the reputed radiologist Fred Lee’s, career. Lee emphasises the importance of different types of treatment in cancer due to the disease’s resilience and discusses revolutionary treatment techniques, including tumour ablation, histotripsy, and how he believes robots will play a role in future treatments.

In this EMJ Podcast, our host Sue Saville is joined by Margareth Ozelo, Associate Professor of the Internal Medicine Department and Director of the Haematology Division, University of Campinas, São Paulo, Brazil, and Radek Kaczmarek, Postdoctoral Research Associate, Gene and Cell Therapy Group, Indiana University School of Medicine, Department of Pediatrics, Indianapolis, Indiana, USA, who speak about the latest developments in gene therapy for haemophilia.

This podcast has been funded by a Pfizer educational grant, in which the position and discussions might not represent the position of Pfizer.

This week Jonathan is joined by Hugo Davila, board-certified urologist and Clinical Assistant Professor at Florida State University, College of Medicine, Florida, USA. The pair discussed the latest innovations in the field of urology, including the use of robotics. Pertinent topics included little-discussed pathologies such as female pelvic organ prolapses and Peyronie's disease.

This week, Smeeta Sinha, Consultant Nephrologist at the Salford Royal Hospital, Manchester, UK and Visiting Professor at Manchester Metropolitan University, UK, joins Jonathan to explore renal healthcare. In this episode, the pair discuss Prof Sinha’s fascinating career, including her role in the research of calciphylaxis treatment and management. A range of pertinent topics are discussed, including the importance of patient awareness of diabetic kidney disease, and how simple innovative strategies can have a hugely positive impact on patients.

In this week’s episode, Jonathan Sackier, surgeon, innovator, and entrepreneur, explores the history and uses of regenerative medicine while highlighting its different to transplantation. Comparing the protein P53 to Kim Kardashian, Jonathan contemplates the uses of other proteins as well as the different types of regenerative medicine, including gene therapies and the use of petroleum-based prosthetics. He even provides hints to his latest project in the field and elaborates on the use of scaffolding in regenerative medicine.

This content has been funded by Novartis, the position and discussions might not represent the position of Novartis. The content was intended for non-USA and non-UK healthcare professionals.

This EMG Health podcast kicks off with Bridget Scott introducing two experts, David Ilson, Medical Oncologist, Memorial Sloan Kettering Cancer Center, Gastrointestinal Oncology, New York, USA, and Samuel Klempner, Associate Professor, Massachusetts General Hospital, Harvard Medical School, USA, who discuss critical unmet needs in the management of patients with oesophageal cancer.

This week, Peter Arkwright, Senior Lecturer in Paediatric Allergy and Immunology, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK, and Consultant for the Department of Paediatric Allergy and Immunology, Manchester University Foundation NHS Trust, UK, joins our Editor, Evgenia Koutsouki, to speak about the prevalence of allergy and the challenges surrounding immune disease in children. In this episode, the pair discuss Dr Arkwright’s fascinating career, including the defining moment of his practice so far. A range of pertinent topics are discussed, including insights into the treatment of novel and life-threatening immune diseases, and the reasons behind the surge in infectious diseases that the world has recently observed.

The Aimee Drew Trust

This podcast was funded by a medical educational grant from AstraZeneca, with the purpose of enhancing the fundamental understanding of oncology specialists of the value of a multidisciplinary team approach in the management of patients with cancer.

In this EMJ Podcast, our host Brigitte Scott is joined by experts David Baldwin, Honorary Professor, School of Medicine, University of Nottingham, UK, Michelle Greenwood, Uro-oncology Clinical Nurse Specialist and Lead Teenage and Young Adult Nurse, St. Bartholomew’s Health NHS Trust, London, UK; and Kerry Archer, Cancer Specialist Physiotherapist, Active Against Cancer, Harrogate & District NHS Foundation Trust, UK, who share their perspectives on the multidisciplinary team (MDT)–patient dynamic and the importance of patient empowerment in multidisciplinary cancer care.